scispace - formally typeset
M

Mar Lorente

Researcher at Complutense University of Madrid

Publications -  57
Citations -  10132

Mar Lorente is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Cannabinoid & Cancer. The author has an hindex of 29, co-authored 54 publications receiving 8292 citations. Previous affiliations of Mar Lorente include Spanish National Research Council & Salisbury University.

Papers
More filters
Journal ArticleDOI

TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling.

TL;DR: It is found that Tribbles pseudokinase 3 (TRIB3) plays a tumor suppressor role and that this effect relies on the dysregulation of the phosphorylation of v-akt murine thymoma viral oncogene homolog (AKT) by the mammalian target of rapamycin complex 2 (mTORC2 complex), and the subsequent hyperphosphorylation and inactivation of the transcription factor Forkhead box O3 (FOXO3).
Patent

Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)

TL;DR: In this paper, the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer.
Journal ArticleDOI

Oncosuppressive functions of tribbles pseudokinase 3

TL;DR: Observation obtained by laboratories supporting that TRIB3 plays a crucial role in the anti-cancer activity of cannabinoids (a novel family of potential anti- cancer agents derived from marijuana) and thatTRIB3 genetic inactivation enhances cancer generation and progression are summarized.